NEW DELHI: Serum Institute of India (SII) is doing its best to ramp up the production of Covid-19 vaccine Covishield to cater to demand in the country, Adar Poonawalla said on Saturday.
Responding to a tweet by JSW Group Chairman Sajjan Jindal, Poonawalla said the vaccine major is doing its best to introduce vaccines on priority for the Indian market. Yes@sajjanjindal, we at @SerumInstIndia are doing our best to ramp up production & launch new vaccines on priority for India. We are grateful for @TheJSWGroup efforts in trying to fulfill India s medical oxygen needs as we stand together in this fight against this pandemic, Poonawalla said in a tweet.
JSW Ispat Special Products reports consolidated net profit of Rs 93 33 crore in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
ದಿನದಿಂದ ದಿನಕ್ಕೆ ಕೊರೋನಾ ಸೋಂಕು ಏರಿಕೆ: ಲಾಕ್ ಡೌನ್ ಹೇರಿಕೆಗೆ ಹೆಚ್ಚುತ್ತಿರುವ ಒತ್ತಡ!
kannadaprabha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kannadaprabha.com Daily Mail and Mail on Sunday newspapers.